166 related articles for article (PubMed ID: 26809940)
21. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.
Cervero M; Torres R; Agud JL; Alcázar V; Jusdado JJ; García-Lacalle C; Moreno S
PLoS One; 2018; 13(4):e0196201. PubMed ID: 29709013
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates for the prevention and treatment of osteoporosis.
Maraka S; Kennel KA
BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
[TBL] [Abstract][Full Text] [Related]
24. Management of osteoporosis in rheumatoid arthritis patients.
Hoes JN; Bultink IE; Lems WF
Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
[TBL] [Abstract][Full Text] [Related]
25. HIV infection and bone disease.
Compston J
J Intern Med; 2016 Oct; 280(4):350-8. PubMed ID: 27272530
[TBL] [Abstract][Full Text] [Related]
26. Bone loss in patients with HIV infection.
Paccou J; Viget N; Legrout-Gérot I; Yazdanpanah Y; Cortet B
Joint Bone Spine; 2009 Dec; 76(6):637-41. PubMed ID: 19945322
[TBL] [Abstract][Full Text] [Related]
27. Bone loss in HIV: a contemporary review.
Hileman CO; Eckard AR; McComsey GA
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):446-51. PubMed ID: 26414081
[TBL] [Abstract][Full Text] [Related]
28. [Metabolic bone disorders in HIV patients].
Reisfeld S; Chowers M
Harefuah; 2013 Apr; 152(4):238-41, 245. PubMed ID: 23844528
[TBL] [Abstract][Full Text] [Related]
29. Bone disease in HIV infection: a practical review and recommendations for HIV care providers.
McComsey GA; Tebas P; Shane E; Yin MT; Overton ET; Huang JS; Aldrovandi GM; Cardoso SW; Santana JL; Brown TT
Clin Infect Dis; 2010 Oct; 51(8):937-46. PubMed ID: 20839968
[TBL] [Abstract][Full Text] [Related]
30. Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.
Cortés YI; Yin MT; Reame NK
J Assoc Nurses AIDS Care; 2015; 26(4):387-98. PubMed ID: 26066693
[TBL] [Abstract][Full Text] [Related]
31. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review.
Carvalho EH; Gelenske T; Bandeira F; Albuquerque Mda F
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):133-42. PubMed ID: 20485901
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis and multiple fractures in an antiretroviral-naive, HIV-positive child.
Soler Palacin P; Torrent A; Rossich R; Moraga FA; Yeste D; Carreño JC; Encabo G; Figueras C
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):933-8. PubMed ID: 17937065
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years.
Negredo E; Bonjoch A; Pérez-Álvarez N; Ornelas A; Puig J; Herrero C; Estany C; del Río L; di Gregorio S; Echeverría P; Clotet B
HIV Med; 2015 Aug; 16(7):441-8. PubMed ID: 25944411
[TBL] [Abstract][Full Text] [Related]
35. Osteoporosis and bone health in HIV.
Powderly WG
Curr HIV/AIDS Rep; 2012 Sep; 9(3):218-22. PubMed ID: 22581359
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous supracondylar femoral fracture in an HIV patient in lotus position.
Pinto Neto LF; Eis SR; Miranda AE
J Clin Densitom; 2011; 14(1):74-6. PubMed ID: 21295744
[TBL] [Abstract][Full Text] [Related]
37. Recommendations for evaluation and management of bone disease in HIV.
Brown TT; Hoy J; Borderi M; Guaraldi G; Renjifo B; Vescini F; Yin MT; Powderly WG
Clin Infect Dis; 2015 Apr; 60(8):1242-51. PubMed ID: 25609682
[TBL] [Abstract][Full Text] [Related]
38. Osteoporosis and HIV Infection.
Biver E
Calcif Tissue Int; 2022 May; 110(5):624-640. PubMed ID: 35098324
[TBL] [Abstract][Full Text] [Related]
39. Bone disease in the setting of HIV infection: update and review of the literature.
Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
[TBL] [Abstract][Full Text] [Related]
40. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
J Clin Endocrinol Metab; 2007 Apr; 92(4):1283-8. PubMed ID: 17227801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
